Literature DB >> 27496873

A mutation in the glutamate-rich region of RNA-binding motif protein 20 causes dilated cardiomyopathy through missplicing of titin and impaired Frank-Starling mechanism.

Abdelaziz Beqqali1, Ilse A E Bollen2, Torsten B Rasmussen3, Maarten M van den Hoogenhof4, Hanneke W M van Deutekom4, Sebastian Schafer5, Jan Haas6, Benjamin Meder6, Keld E Sørensen3, Ralph J van Oort4, Jens Mogensen7, Norbert Hubner8, Esther E Creemers4, Jolanda van der Velden2, Yigal M Pinto4.   

Abstract

AIM: Mutations in the RS-domain of RNA-binding motif protein 20 (RBM20) have recently been identified to segregate with aggressive forms of familial dilated cardiomyopathy (DCM). Loss of RBM20 in rats results in missplicing of the sarcomeric gene titin (TTN). The functional and physiological consequences of RBM20 mutations outside the mutational hotspot of RBM20 have not been explored to date. In this study, we investigated the pathomechanism of DCM caused by a novel RBM20 mutation in human cardiomyocytes. METHODS AND
RESULTS: We identified a family with DCM carrying a mutation (RBM20(E913K/+)) in a glutamate-rich region of RBM20. Western blot analysis of endogenous RBM20 protein revealed strongly reduced protein levels in the heart of an RBM20(E913K/+ )carrier. RNA deep-sequencing demonstrated massive inclusion of exons coding for the spring region of titin in the RBM20(E913K/+ )carrier. Titin isoform analysis revealed a dramatic shift from the less compliant N2B towards the highly compliant N2BA isoforms in RBM20(E913K/+ )heart. Moreover, an increased sarcomere resting-length was observed in single cardiomyocytes and isometric force measurements revealed an attenuated Frank-Starling mechanism (FSM), which was rescued by protein kinase A treatment.
CONCLUSION: A mutation outside the mutational hotspot of RBM20 results in haploinsufficiency of RBM20. This leads to disturbed alternative splicing of TTN, resulting in a dramatic shift to highly compliant titin isoforms and an impaired FSM. These effects may contribute to the early onset, and malignant course of DCM caused by RBM20 mutations. Altogether, our results demonstrate that heterozygous loss of RBM20 suffices to profoundly impair myocyte biomechanics by its disturbance of TTN splicing. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2016. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Alternative splicing; Cardiomyopathy; Dilated cardiomyopathy; Heart failure; RBM20; Sarcomere

Mesh:

Substances:

Year:  2016        PMID: 27496873     DOI: 10.1093/cvr/cvw192

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  38 in total

Review 1.  Dilated Cardiomyopathy: Genetic Determinants and Mechanisms.

Authors:  Elizabeth M McNally; Luisa Mestroni
Journal:  Circ Res       Date:  2017-09-15       Impact factor: 17.367

Review 2.  Alternative splicing as a regulator of development and tissue identity.

Authors:  Francisco E Baralle; Jimena Giudice
Journal:  Nat Rev Mol Cell Biol       Date:  2017-05-10       Impact factor: 94.444

Review 3.  Role of titin in cardiomyopathy: from DNA variants to patient stratification.

Authors:  James S Ware; Stuart A Cook
Journal:  Nat Rev Cardiol       Date:  2017-12-14       Impact factor: 32.419

4.  In heart failure reactivation of RNA-binding proteins is associated with the expression of 1,523 fetal-specific isoforms.

Authors:  Matteo D'Antonio; Jennifer P Nguyen; Timothy D Arthur; Hiroko Matsui; Margaret K R Donovan; Agnieszka D'Antonio-Chronowska; Kelly A Frazer
Journal:  PLoS Comput Biol       Date:  2022-02-28       Impact factor: 4.475

5.  Beneficial Effects of Cardiomyopathy-Associated Genetic Variants on Physical Performance: A Hypothesis-Generating Scoping Review.

Authors:  Sjoerd M Verwijs; Yigal M Pinto; Diederik W D Kuster; Jolanda van der Velden; Jacqueline Limpens; Juliette C van Hattum; Saskia N van der Crabben; Ronald H Lekanne Deprez; Arthur A M Wilde; Harald T Jørstad
Journal:  Cardiology       Date:  2021-10-27       Impact factor: 1.869

6.  I536T variant of RBM20 affects splicing of cardiac structural proteins that are causative for developing dilated cardiomyopathy.

Authors:  Takuma Yamamoto; Rie Sano; Aya Miura; Mai Imasaka; Yoshiro Naito; Minori Nishiguchi; Kensuke Ihara; Naruhito Otani; Yoshihiko Kominato; Masaki Ohmuraya; Hidehito Kuroyanagi; Hajime Nishio
Journal:  J Mol Med (Berl)       Date:  2022-10-05       Impact factor: 5.606

7.  RBM20S639G mutation is a high genetic risk factor for premature death through RNA-protein condensates.

Authors:  Chunyan Wang; Yanghai Zhang; Mei Methawasin; Camila Urbano Braz; Jeffrey Gao-Hu; Betty Yang; Joshua Strom; Jochen Gohlke; Timothy Hacker; Hasan Khatib; Henk Granzier; Wei Guo
Journal:  J Mol Cell Cardiol       Date:  2022-01-15       Impact factor: 5.000

8.  Increased myocyte calcium sensitivity in end-stage pediatric dilated cardiomyopathy.

Authors:  Stephanie J Nakano; John S Walker; Lori A Walker; Xiaotao Li; Yanmei Du; Shelley D Miyamoto; Carmen C Sucharov; Anastacia M Garcia; Max B Mitchell; Amrut V Ambardekar; Brian L Stauffer
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-10-18       Impact factor: 4.733

9.  A gene-centric strategy for identifying disease-causing rare variants in dilated cardiomyopathy.

Authors:  Claire Horvat; Renee Johnson; Lien Lam; Jacob Munro; Francesco Mazzarotto; Angharad M Roberts; Daniel S Herman; Michael Parfenov; Alireza Haghighi; Barbara McDonough; Steven R DePalma; Anne M Keogh; Peter S Macdonald; Christopher S Hayward; Amy Roberts; Paul J R Barton; Leanne E Felkin; Eleni Giannoulatou; Stuart A Cook; J G Seidman; Christine E Seidman; Diane Fatkin
Journal:  Genet Med       Date:  2018-06-11       Impact factor: 8.822

10.  The Combined Human Genotype of Truncating TTN and RBM20 Mutations Is Associated with Severe and Early Onset of Dilated Cardiomyopathy.

Authors:  Anna Gaertner; Julia Bloebaum; Andreas Brodehl; Baerbel Klauke; Katharina Sielemann; Astrid Kassner; Henrik Fox; Michiel Morshuis; Jens Tiesmeier; Uwe Schulz; Ralph Knoell; Jan Gummert; Hendrik Milting
Journal:  Genes (Basel)       Date:  2021-06-08       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.